Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Clinical trial NCT02349633 · TERMINATED
Trial details
- NCT number
- NCT02349633
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-14
- Primary completion
- 2020-05-28
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.